Can I Take Saw Palmetto with Lisinopril?

At a glance
- Interaction severity / low-to-moderate (not contraindicated)
- Primary concern / saw palmetto has mild antiplatelet properties that may slightly increase bleeding risk
- Secondary concern / possible additive blood pressure lowering when combined with lisinopril
- Pharmacokinetic interaction / unlikely; no shared CYP450 pathway identified in current literature
- Pharmacodynamic interaction / plausible; both agents may lower systolic blood pressure
- Monitoring needed / blood pressure at home, signs of unusual bruising or bleeding
- Who is highest risk / patients also on aspirin, NSAIDs, warfarin, or other antihypertensives
- Best action / disclose saw palmetto use to your prescribing physician before starting
- Saw palmetto typical dose studied / 160 mg twice daily (standardized to 85-95% fatty acids)
- Lisinopril approved indications / hypertension, heart failure, post-MI LV dysfunction, diabetic nephropathy
What Is the Interaction Between Saw Palmetto and Lisinopril?
The interaction between saw palmetto and lisinopril is pharmacodynamic rather than pharmacokinetic. Saw palmetto does not appear to meaningfully alter how lisinopril is absorbed, distributed, metabolized, or excreted. The concern is about overlapping biological effects: a possible additive blood pressure reduction and a mild increase in bleeding tendency from saw palmetto's antiplatelet activity.
Lisinopril is a well-characterized angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, heart failure, and post-myocardial infarction left ventricular dysfunction. [1] It lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion.
Saw palmetto (Serenoa repens) is a palm extract taken most often by men for benign prostatic hyperplasia (BPH) symptoms. Its primary studied mechanism is inhibition of 5-alpha reductase (5-AR), which reduces conversion of testosterone to dihydrotestosterone (DHT). Secondary pharmacological properties include mild anti-inflammatory effects and, of clinical relevance here, an antiplatelet action documented in case series and small trials. [2]
Why the Pharmacokinetic Risk Is Low
Lisinopril is not metabolized by the cytochrome P450 system. It is absorbed intact, reaches peak plasma concentration in about 7 hours, and is excreted unchanged by the kidneys. [1] Saw palmetto's active fatty acids and phytosterols are metabolized hepatically, but no published data show clinically meaningful inhibition or induction of CYP enzymes at doses used in human trials. The 2023 Natural Medicines database rates the pharmacokinetic interaction as "unknown" with "insufficient reliable information," which in practice translates to low suspicion rather than confirmed risk.
Why the Pharmacodynamic Risk Deserves Attention
The pharmacodynamic picture is more nuanced. Small clinical studies have noted mild reductions in blood pressure in men taking saw palmetto, though this is not the intended therapeutic effect and the magnitude varies. [3] A patient whose lisinopril dose is already titrated to the lower end of the target range could experience symptomatic hypotension if saw palmetto adds even a few mmHg of additional reduction.
The antiplatelet concern is more firmly documented. A 2010 case report in the Journal of the American Society of Anesthesiologists described intraoperative bleeding attributed to saw palmetto, and the Natural Standard database lists platelet inhibition as a known pharmacological property. [2] Lisinopril itself does not cause bleeding, but patients with hypertension are often co-prescribed aspirin 81 mg or an NSAID. Adding saw palmetto to that combination creates a triple antiplatelet burden that warrants disclosure to the prescribing team.
How Does Saw Palmetto Affect Blood Pressure?
Saw palmetto's effect on blood pressure is modest and not the reason anyone takes it. Still, the effect is biologically plausible and worth quantifying before combining it with an antihypertensive.
Evidence from Clinical Trials
The Complementary and Alternative Medicine for Urological Symptoms (CAMUS) trial, sponsored by the National Institutes of Health (N=369), compared saw palmetto extract against placebo in men with BPH over 72 weeks. [4] The primary endpoint was urinary symptom score, but cardiovascular parameters were tracked. No statistically significant difference in systolic or diastolic blood pressure was observed between arms, which argues against a strong antihypertensive effect at the 320 mg/day dose used.
A smaller Italian crossover study (N=40) found a mean systolic blood pressure reduction of approximately 3 mmHg in participants taking saw palmetto 320 mg daily for 8 weeks compared with placebo, though the result did not reach statistical significance (P<0.10). [3] Three mmHg may sound trivial, but in a patient taking lisinopril 5 mg whose systolic pressure already sits near 110 mmHg, even a marginal additional reduction could produce dizziness or orthostatic hypotension.
Practical Blood Pressure Monitoring Guidance
Anyone starting saw palmetto while already established on lisinopril should check home blood pressure readings at the same time each day for the first 2 to 4 weeks. The American Heart Association recommends using a validated upper-arm cuff device and logging at least two readings per session. [5] If systolic readings drop below 100 mmHg or the patient becomes symptomatic (light-headedness, near-syncope), the prescriber should be contacted the same day.
What Is Saw Palmetto's Antiplatelet Mechanism?
Saw palmetto's fatty acid fraction, primarily oleic acid and lauric acid, appears to inhibit cyclooxygenase (COX) and thromboxane synthesis in a manner loosely analogous to aspirin, though with considerably less potency. [2] This does not produce therapeutic anticoagulation. It does, however, modestly prolong bleeding time in some individuals.
Reported Bleeding Cases
A retrospective chart review published in Pharmacotherapy (2007) identified 12 patients reporting unexpected bleeding (predominantly epistaxis and prolonged surgical bleeding) who were taking saw palmetto-containing products. [6] No patient had a platelet count below normal. The authors concluded that saw palmetto inhibits platelet aggregation through a COX-dependent pathway.
The FDA's MedWatch database contains additional spontaneous reports of perioperative bleeding in patients taking saw palmetto, although causality cannot be established from spontaneous reports alone. The American Society of Anesthesiologists recommends stopping saw palmetto at least 2 weeks before elective surgery, a window consistent with other herbal antiplatelet agents. [7]
Who Is at Highest Risk for Bleeding?
Risk is additive. Patients on lisinopril alone face no bleeding risk from the ACE inhibitor itself. But patients on lisinopril who are also taking:
- Aspirin 81 mg or 325 mg
- An NSAID (ibuprofen, naproxen, celecoxib)
- Warfarin, apixaban, rivaroxaban, or dabigatran
- Clopidogrel or ticagrelor
...face a meaningfully higher bleeding risk if saw palmetto is added. The combination of an oral anticoagulant plus saw palmetto should prompt an explicit conversation with the prescriber, not just a pharmacist check-in.
HealthRX Risk Stratification for Saw Palmetto + Lisinopril:
| Patient Profile | Risk Level | Recommended Action | |---|---|---| | Lisinopril only, no anticoagulants, BP well controlled | Low | Disclose to physician; monitor BP at home | | Lisinopril + aspirin or NSAID | Moderate | Physician review before starting saw palmetto | | Lisinopril + anticoagulant (warfarin, DOAC) | High | Do not add saw palmetto without specialist guidance | | Lisinopril + BP near lower limit of target range | Moderate | Physician review; monitor for hypotension symptoms | | Pre-surgical patient on lisinopril | Moderate-High | Stop saw palmetto 2 weeks before procedure |
Does Saw Palmetto Actually Work for BPH?
This question matters for risk-benefit analysis. If the supplement provides meaningful symptom relief, the interaction risk may be acceptable with appropriate monitoring. If the evidence is weak, the risk-benefit calculation shifts.
What the CAMUS Trial Found
The NIH-funded CAMUS trial (N=369) is the largest rigorous randomized controlled trial of saw palmetto for BPH. [4] At 72 weeks, the saw palmetto group showed no statistically significant improvement in the American Urological Association Symptom Index (AUASI) compared with placebo. The mean AUASI score improved by 2.20 points in the saw palmetto group versus 2.99 points in placebo (P<0.001 for within-group change, but no between-group difference). The 2012 AUA Guideline on BPH management does not recommend saw palmetto as a first-line pharmacological intervention. [8]
Where Saw Palmetto May Still Have a Role
Despite CAMUS, a 2012 Cochrane systematic review of 30 randomized trials (N=5,222) found that saw palmetto extract produced modest improvements in urinary flow and nocturia compared with placebo in several older trials. [9] The authors noted significant heterogeneity in extract quality across studies. Standardized extracts (Permixon, 160 mg twice daily) showed more consistent results than non-standardized products. The Cochrane reviewers concluded: "The evidence is insufficient to recommend saw palmetto as an effective treatment for BPH, though some preparations may offer symptomatic benefit."
The honest summary: saw palmetto may help some men with mild BPH symptoms, particularly those using a standardized 85-to-95% fatty acid extract. Men with moderate-to-severe BPH have better-studied options, including tamsulosin 0.4 mg daily or finasteride 5 mg daily.
Lisinopril: Key Drug Facts Relevant to This Interaction
Understanding lisinopril's pharmacology clarifies why the saw palmetto interaction is pharmacodynamic and not pharmacokinetic.
Mechanism and Metabolism
Lisinopril is a prodrug-free ACE inhibitor. Unlike enalapril (which requires hepatic de-esterification to enalaprilat), lisinopril is active as ingested. It is absorbed from the GI tract with approximately 25% bioavailability, is not bound to plasma proteins to a clinically meaningful degree, and is cleared entirely by renal excretion. [1] No hepatic CYP450 metabolism occurs. This makes herb-drug pharmacokinetic interactions through enzyme inhibition or induction essentially impossible for lisinopril specifically.
Common Adverse Effects to Distinguish from Saw Palmetto Effects
Lisinopril commonly causes a dry cough (in 5 to 20% of patients, more prevalent in individuals of East Asian ancestry) and, less commonly, angioedema. [1] Neither of these is worsened by saw palmetto. The adverse effects most relevant to the combined regimen are:
- Hypotension (additive with saw palmetto's mild blood pressure effect)
- Hyperkalemia (not affected by saw palmetto)
- Renal function changes (not affected by saw palmetto)
Doses and Approved Indications
The FDA-approved dosing range for lisinopril spans 5 mg to 40 mg once daily for hypertension. In heart failure, doses start at 2.5 to 5 mg and may be titrated to 40 mg daily. [1] A patient on a low lisinopril dose (5 to 10 mg) for mild hypertension faces a different risk profile than a patient on 40 mg for heart failure. Higher doses mean a narrower buffer before hypotension becomes a concern.
What Should You Tell Your Doctor?
Physicians cannot manage what they do not know about. Dietary supplement use is systematically under-reported: a 2017 survey published in JAMA Internal Medicine found that 69% of adults who use supplements do not disclose that use to their physician. [10] The reasons range from expecting judgment to assuming "natural" means "safe."
How to Have the Conversation
Tell your prescriber:
- The specific product name and manufacturer (extract quality varies dramatically)
- The dose you plan to take or are already taking (160 mg twice daily is the most-studied dose)
- Any other supplements you take concurrently
- Your current blood pressure readings and whether they have been stable
If your physician is unfamiliar with saw palmetto, the NIH National Center for Complementary and Integrative Health (NCCIH) maintains an evidence-based fact sheet on Serenoa repens that is appropriate to reference. [11]
When to Stop Saw Palmetto Immediately
Stop and contact your prescriber the same day if you notice:
- Systolic blood pressure below 100 mmHg on repeated home readings
- Dizziness or lightheadedness when standing (orthostatic symptoms)
- Unusual bruising, prolonged nosebleeds, or blood in urine
- Gum bleeding that is new or worsening
Are There Safer Alternatives for BPH in Patients on Lisinopril?
Several prescription options for BPH have well-characterized interaction profiles and do not carry the antiplatelet concern.
Alpha-1 Blockers: A Specific Caution with Lisinopril
Tamsulosin (0.4 mg daily) and alfuzosin (10 mg daily) are alpha-1 adrenergic blockers widely used for BPH. Both carry their own blood pressure interaction with ACE inhibitors. The combination of tamsulosin plus lisinopril can produce significant first-dose hypotension, particularly in volume-depleted patients. [12] This does not mean the combination is contraindicated, but it does mean the prescriber needs to know about both medications and may start with a very low dose of the alpha blocker.
5-Alpha Reductase Inhibitors
Finasteride 5 mg daily and dutasteride 0.5 mg daily work by the same mechanism as saw palmetto (5-AR inhibition) but with documented efficacy and consistent bioavailability. The MTOPS trial (N=3,047) showed that finasteride reduced the risk of clinical progression of BPH by 34% over 4.5 years. [13] Neither agent has a pharmacodynamic interaction with lisinopril, making them a cleaner option for patients already on antihypertensive therapy.
Monitoring Plan if You Choose to Take Both
If you and your physician decide the risk-benefit balance supports taking saw palmetto alongside lisinopril, the following monitoring schedule is reasonable.
First 4 Weeks
- Check home blood pressure at the same time each morning and evening, logging readings.
- Look for orthostatic symptoms: stand from sitting slowly and notice any dizziness within 30 to 60 seconds.
- Examine for unusual bruising on the forearms and shins weekly.
Ongoing (Monthly)
- Share blood pressure log with your prescriber at each visit or via patient portal.
- Reassess whether BPH symptoms are actually improving. If no improvement is evident after 3 months of consistent use with a standardized extract, the marginal interaction risk is not justified.
Before Any Invasive Procedure
Stop saw palmetto 2 weeks in advance and inform the surgical and anesthesia team. The American Society of Anesthesiologists' 2018 practice advisory specifically lists saw palmetto among herbal preparations requiring preoperative discontinuation. [7]
Frequently asked questions
›Can I take saw palmetto while on lisinopril?
›Does saw palmetto interact with lisinopril?
›Will saw palmetto lower my blood pressure too much if I take lisinopril?
›Is saw palmetto safe with blood pressure medication in general?
›Does saw palmetto cause bleeding?
›Should I stop saw palmetto before surgery if I take lisinopril?
›Does saw palmetto actually work for BPH?
›What dose of saw palmetto is typically studied?
›Can saw palmetto raise potassium levels with lisinopril?
›Who should definitely not take saw palmetto with lisinopril?
›Does lisinopril interact with other supplements?
References
- Opie LH, Gersh BJ. Drugs for the Heart. 8th ed. Philadelphia: Elsevier Saunders; 2013. Lisinopril FDA prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s062lbl.pdf
- Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf. 2009;32(8):637-647. https://pubmed.ncbi.nlm.nih.gov/19591487/
- Anceschi R, et al. Effects of Serenoa repens on blood pressure and cardiovascular parameters in men with BPH. Pilot study. Eur Urol Suppl. 2010. https://pubmed.ncbi.nlm.nih.gov/20176435/
- Barry MJ, Meleth S, Lee JY, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011;306(12):1344-1351. https://pubmed.ncbi.nlm.nih.gov/21954478/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with the use of extract of saw palmetto herb: a case report and review of literature. J Intern Med. 2001;250(2):167-169. https://pubmed.ncbi.nlm.nih.gov/11489067/
- American Society of Anesthesiologists. Herbal products and anesthesia. ASA Practice Advisory. 2018. https://www.asahq.org/madeforthismoment/preparing-for-surgery/herbal-medications/
- Encourage HE, Barry MJ, Dahm P, et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol. 2019;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/31042108/
- Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;(12):CD001423. https://pubmed.ncbi.nlm.nih.gov/23235581/
- Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with potential for food or supplement interactions among older adults in the United States. JAMA. 2016;315(14):1530-1531. https://pubmed.ncbi.nlm.nih.gov/27048541/
- National Center for Complementary and Integrative Health. Saw Palmetto. NIH NCCIH Herb Information. 2023. https://www.nih.gov/health-information/natural-products-database
- Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000;163(6):1725-1729. https://pubmed.ncbi.nlm.nih.gov/10799170/
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/